First FDA-Approved Treatment For Patients With Focal Segmental Glomerulosclerosis, A Rare Kidney Condition
Benzinga Newsdesk 7 months ago
BiotechNewsFDAGeneral
https://www.fda.gov/drugs/drug-alerts-and-statements/first-fda-approved-treatment-patients-focal-segmental-glomerulosclerosis-rare-kidney-condition